Pneumonia Vaccine Market 2027 By Vaccine Type, Product Type, Distribution Channel and Geography | The Insight Partners

Pneumonia Vaccine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Vaccine Type (Pneumococcal Polysaccharide Vaccine (PPSV/PPV), Pneumococcal Conjugate Vaccine (PCV)) ; Product Type (Prevnar 13, Synflorix, Pneumovax23) ; Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography

Report Code: TIPRE00008672 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Pneumonia is one of the types of lung infection which is caused due to bacteria, viruses, and fungi. Infants below two years and people over age 65 are highly vulnerable for pneumonia. Additionally, certain habits such as smoking, excessive alcoholism, and lifestyle habits are responsible to cause pneumonia. Chest pain while breathing, nausea, vomiting, shortness of breath, fatigue, and fever are some of the indications of observed in pneumonia.

MARKET DYNAMICS

Increasing prevalence of pneumonia amongst the population is likely to drive the growth of the pneumonia vaccines market during the forecast period. Moreover, aging population coupled with excessive alcoholism is also directly have impact on growth of the pneumonia patients, which will in turn anticipated to drive the market growth.

MARKET SCOPE

The "Pneumonia Vaccine Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pneumonia Vaccine Market with detailed market segmentation by vaccine type, product type, distribution channel and geography. The Pneumonia Vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Pneumonia Vaccine Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Pneumonia Vaccine Market is segmented on the basis by vaccine type, product type, and distribution channel. Based on vaccine type, the market is segmented into pneumococcal polysaccharide vaccine (PPSV/PPV) and pneumococcal conjugate vaccine (PCV). On the basis of product type, the market is segmented as Prevnar 13, Synflorix, and Pneumovax23. ON the basis on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and others.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Pneumonia Vaccine Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pneumonia Vaccine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pneumonia Vaccine Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pneumonia Vaccine Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Pneumonia Vaccine Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pneumonia Vaccine Market are anticipated to lucrative growth opportunities in the future with the rising demand for Pneumonia Vaccine Market in the global market. Below mentioned is the list of few companies engaged in the Pneumonia Vaccine Market.

The report also includes the profiles of key Pneumonia Vaccine Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Pfizer
- GlaxoSmithKline plc.
- Merck & Co., Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pneumonia Vaccine Market - By Vaccine Type
1.3.2 Pneumonia Vaccine Market - By Product Type
1.3.3 Pneumonia Vaccine Market - By Distribution Channel
1.3.4 Pneumonia Vaccine Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PNEUMONIA VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PNEUMONIA VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PNEUMONIA VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PNEUMONIA VACCINE - GLOBAL MARKET OVERVIEW
6.2. PNEUMONIA VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PNEUMONIA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPSV/PPV)
7.3.1. Overview
7.3.2. Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market Forecast and Analysis
7.4. PNEUMOCOCCAL CONJUGATE VACCINE (PCV)
7.4.1. Overview
7.4.2. Pneumococcal Conjugate Vaccine (PCV) Market Forecast and Analysis
8. PNEUMONIA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
8.1. OVERVIEW
8.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
8.3. PREVNAR 13
8.3.1. Overview
8.3.2. Prevnar 13 Market Forecast and Analysis
8.4. SYNFLORIX
8.4.1. Overview
8.4.2. Synflorix Market Forecast and Analysis
8.5. PNEUMOVAX23
8.5.1. Overview
8.5.2. Pneumovax23 Market Forecast and Analysis
9. PNEUMONIA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. PNEUMONIA VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pneumonia Vaccine Market Overview
10.1.2 North America Pneumonia Vaccine Market Forecasts and Analysis
10.1.3 North America Pneumonia Vaccine Market Forecasts and Analysis - By Vaccine Type
10.1.4 North America Pneumonia Vaccine Market Forecasts and Analysis - By Product Type
10.1.5 North America Pneumonia Vaccine Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pneumonia Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pneumonia Vaccine Market
10.1.6.1.1 United States Pneumonia Vaccine Market by Vaccine Type
10.1.6.1.2 United States Pneumonia Vaccine Market by Product Type
10.1.6.1.3 United States Pneumonia Vaccine Market by Distribution Channel
10.1.6.2 Canada Pneumonia Vaccine Market
10.1.6.2.1 Canada Pneumonia Vaccine Market by Vaccine Type
10.1.6.2.2 Canada Pneumonia Vaccine Market by Product Type
10.1.6.2.3 Canada Pneumonia Vaccine Market by Distribution Channel
10.1.6.3 Mexico Pneumonia Vaccine Market
10.1.6.3.1 Mexico Pneumonia Vaccine Market by Vaccine Type
10.1.6.3.2 Mexico Pneumonia Vaccine Market by Product Type
10.1.6.3.3 Mexico Pneumonia Vaccine Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pneumonia Vaccine Market Overview
10.2.2 Europe Pneumonia Vaccine Market Forecasts and Analysis
10.2.3 Europe Pneumonia Vaccine Market Forecasts and Analysis - By Vaccine Type
10.2.4 Europe Pneumonia Vaccine Market Forecasts and Analysis - By Product Type
10.2.5 Europe Pneumonia Vaccine Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pneumonia Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pneumonia Vaccine Market
10.2.6.1.1 Germany Pneumonia Vaccine Market by Vaccine Type
10.2.6.1.2 Germany Pneumonia Vaccine Market by Product Type
10.2.6.1.3 Germany Pneumonia Vaccine Market by Distribution Channel
10.2.6.2 France Pneumonia Vaccine Market
10.2.6.2.1 France Pneumonia Vaccine Market by Vaccine Type
10.2.6.2.2 France Pneumonia Vaccine Market by Product Type
10.2.6.2.3 France Pneumonia Vaccine Market by Distribution Channel
10.2.6.3 Italy Pneumonia Vaccine Market
10.2.6.3.1 Italy Pneumonia Vaccine Market by Vaccine Type
10.2.6.3.2 Italy Pneumonia Vaccine Market by Product Type
10.2.6.3.3 Italy Pneumonia Vaccine Market by Distribution Channel
10.2.6.4 Spain Pneumonia Vaccine Market
10.2.6.4.1 Spain Pneumonia Vaccine Market by Vaccine Type
10.2.6.4.2 Spain Pneumonia Vaccine Market by Product Type
10.2.6.4.3 Spain Pneumonia Vaccine Market by Distribution Channel
10.2.6.5 United Kingdom Pneumonia Vaccine Market
10.2.6.5.1 United Kingdom Pneumonia Vaccine Market by Vaccine Type
10.2.6.5.2 United Kingdom Pneumonia Vaccine Market by Product Type
10.2.6.5.3 United Kingdom Pneumonia Vaccine Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pneumonia Vaccine Market Overview
10.3.2 Asia-Pacific Pneumonia Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Pneumonia Vaccine Market Forecasts and Analysis - By Vaccine Type
10.3.4 Asia-Pacific Pneumonia Vaccine Market Forecasts and Analysis - By Product Type
10.3.5 Asia-Pacific Pneumonia Vaccine Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pneumonia Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pneumonia Vaccine Market
10.3.6.1.1 Australia Pneumonia Vaccine Market by Vaccine Type
10.3.6.1.2 Australia Pneumonia Vaccine Market by Product Type
10.3.6.1.3 Australia Pneumonia Vaccine Market by Distribution Channel
10.3.6.2 China Pneumonia Vaccine Market
10.3.6.2.1 China Pneumonia Vaccine Market by Vaccine Type
10.3.6.2.2 China Pneumonia Vaccine Market by Product Type
10.3.6.2.3 China Pneumonia Vaccine Market by Distribution Channel
10.3.6.3 India Pneumonia Vaccine Market
10.3.6.3.1 India Pneumonia Vaccine Market by Vaccine Type
10.3.6.3.2 India Pneumonia Vaccine Market by Product Type
10.3.6.3.3 India Pneumonia Vaccine Market by Distribution Channel
10.3.6.4 Japan Pneumonia Vaccine Market
10.3.6.4.1 Japan Pneumonia Vaccine Market by Vaccine Type
10.3.6.4.2 Japan Pneumonia Vaccine Market by Product Type
10.3.6.4.3 Japan Pneumonia Vaccine Market by Distribution Channel
10.3.6.5 South Korea Pneumonia Vaccine Market
10.3.6.5.1 South Korea Pneumonia Vaccine Market by Vaccine Type
10.3.6.5.2 South Korea Pneumonia Vaccine Market by Product Type
10.3.6.5.3 South Korea Pneumonia Vaccine Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pneumonia Vaccine Market Overview
10.4.2 Middle East and Africa Pneumonia Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Pneumonia Vaccine Market Forecasts and Analysis - By Vaccine Type
10.4.4 Middle East and Africa Pneumonia Vaccine Market Forecasts and Analysis - By Product Type
10.4.5 Middle East and Africa Pneumonia Vaccine Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pneumonia Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pneumonia Vaccine Market
10.4.6.1.1 South Africa Pneumonia Vaccine Market by Vaccine Type
10.4.6.1.2 South Africa Pneumonia Vaccine Market by Product Type
10.4.6.1.3 South Africa Pneumonia Vaccine Market by Distribution Channel
10.4.6.2 Saudi Arabia Pneumonia Vaccine Market
10.4.6.2.1 Saudi Arabia Pneumonia Vaccine Market by Vaccine Type
10.4.6.2.2 Saudi Arabia Pneumonia Vaccine Market by Product Type
10.4.6.2.3 Saudi Arabia Pneumonia Vaccine Market by Distribution Channel
10.4.6.3 U.A.E Pneumonia Vaccine Market
10.4.6.3.1 U.A.E Pneumonia Vaccine Market by Vaccine Type
10.4.6.3.2 U.A.E Pneumonia Vaccine Market by Product Type
10.4.6.3.3 U.A.E Pneumonia Vaccine Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pneumonia Vaccine Market Overview
10.5.2 South and Central America Pneumonia Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Pneumonia Vaccine Market Forecasts and Analysis - By Vaccine Type
10.5.4 South and Central America Pneumonia Vaccine Market Forecasts and Analysis - By Product Type
10.5.5 South and Central America Pneumonia Vaccine Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pneumonia Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pneumonia Vaccine Market
10.5.6.1.1 Brazil Pneumonia Vaccine Market by Vaccine Type
10.5.6.1.2 Brazil Pneumonia Vaccine Market by Product Type
10.5.6.1.3 Brazil Pneumonia Vaccine Market by Distribution Channel
10.5.6.2 Argentina Pneumonia Vaccine Market
10.5.6.2.1 Argentina Pneumonia Vaccine Market by Vaccine Type
10.5.6.2.2 Argentina Pneumonia Vaccine Market by Product Type
10.5.6.2.3 Argentina Pneumonia Vaccine Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PNEUMONIA VACCINE MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK AND CO., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. GlaxoSmithKline plc.
3. Merck & Co., Inc.
TIPRE00008672
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking